Stay updated on Nivolumab Combo vs Pemetrexed/Cisplatin in Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combo vs Pemetrexed/Cisplatin in Mesothelioma Clinical Trial page.

Latest updates to the Nivolumab Combo vs Pemetrexed/Cisplatin in Mesothelioma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page’s footer/site version marker changes from **Revision: v3.5.2** to **Revision: v3.5.3**, indicating an update to the ClinicalTrials.gov site release rather than the clinical study details.SummaryDifference0.0%

- Check15 days agoChange DetectedCollaborator name updated from Ono Pharmaceutical Co. Ltd to Ono Pharmaceutical Co., Ltd and the page revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check44 days agoChange DetectedA new publication citation (Five-Year Clinical Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy in CheckMate 743) was added to the Publications section. The page revision was updated to v3.5.0, and the Italy location listing was changed from Napoli to Naples (Naples 80131) to reflect naming in English.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check80 days agoChange DetectedRevision: v3.4.2 replaces v3.4.1. No observable changes to the study details page or its content.SummaryDifference0.0%

- Check88 days agoChange DetectedRevision: v3.4.1 added; Revision: v3.4.0 removed.SummaryDifference0.0%

Stay in the know with updates to Nivolumab Combo vs Pemetrexed/Cisplatin in Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo vs Pemetrexed/Cisplatin in Mesothelioma Clinical Trial page.